Related Experiment Video
Updated: Jun 30, 2026

A Murine Closed-chest Model of Myocardial Ischemia and Reperfusion
Published on: July 17, 2012
Ischemic preconditioning phosphorylates mitogen-activated kinases and heat shock protein 27 in the diabetic rat heart
1Klinik für Anästhesiologie, Universitätsklinikum Düsseldorf, Düsseldorf, Germany. D.Ebel@ic.umcn.nl
Abstract:
Diabetes mellitus blocks protection by ischemic preconditioning (IPC), but the mechanism is not known. We investigated the effect of ischemic preconditioning on mitogen-activated protein kinases (extracellular signal-regulated kinases 1 and 2, c-Jun N-terminal kinases, p38 mitogen-activated kinase) and heat shock protein 27 phosphorylation in diabetic and nondiabetic rat hearts in vivo. Two groups of anaesthetized nondiabetic and diabetic rats underwent a preconditioning protocol (3 cycles of 3 min coronary artery occlusion and 5 min of reperfusion). Two further groups served as untreated controls. Hearts were excised for protein measurements by Western blot. Four additional groups underwent 25 min of coronary occlusion followed by 2 h of reperfusion to induce myocardial infarction. In these animals, infarct size was measured. IPC reduced infarct size in the nondiabetic rats but not in the diabetic animals. In diabetic rats, IPC induced phosphorylation of the mitogen-activated protein kinases and of heat shock protein 27. We conclude that protection by IPC is blocked by diabetes mellitus in the rat heart in vivo without affecting phosphorylation of mitogen-activated protein kinases or heat shock protein 27. Therefore, the blockade mechanism of diabetes mellitus is downstream of mitogen-activated kinases and heat shock protein 27.
Insights
Diabetes mellitus blocks the protective effects of ischemic preconditioning (IPC) in rat hearts. This occurs downstream of mitogen-activated protein kinases and heat shock protein 27 signaling pathways.
Area of Science:
- Cardiovascular Biology
- Metabolic Disease Research
- Cellular Signaling
Background:
- Ischemic preconditioning (IPC) offers cardioprotection, but its efficacy is diminished in diabetes mellitus.
- The underlying mechanisms by which diabetes impairs IPC remain largely unknown.
Purpose of the Study:
- To investigate the impact of diabetes on IPC-induced cardioprotection in a rat model.
- To examine the role of mitogen-activated protein kinases (MAPKs) and heat shock protein 27 (HSP27) phosphorylation in the diabetic heart's response to IPC.
Main Methods:
- Nondiabetic and diabetic rats underwent IPC protocols (coronary artery occlusion/reperfusion).
- Myocardial infarct size was measured after prolonged ischemia/reperfusion.
- Western blot analysis was used to assess MAPK (ERK1/2, JNK, p38) and HSP27 phosphorylation levels in heart tissue.
Main Results:
- IPC significantly reduced infarct size in nondiabetic rats but failed to provide protection in diabetic rats.
- Despite the lack of protection, IPC induced phosphorylation of MAPKs and HSP27 in diabetic rat hearts.
- Diabetes mellitus blocks IPC-induced cardioprotection without affecting MAPK or HSP27 phosphorylation.
Conclusions:
- The protective mechanism of IPC is blocked by diabetes mellitus in the rat heart.
- The blockade mechanism operates downstream of MAPK and HSP27 signaling pathways.

